Medline, Inc. (MDLN)
42.73
-0.86
(-1.97%)
USD |
NASDAQ |
Mar 20, 16:00
42.30
-0.43
(-1.01%)
After-Hours: 20:00
Medline EPS Diluted (Quarterly) : 0.2241 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TransMedics Group, Inc. | 2.576 |
| Johnson & Johnson | 2.098 |
| Hims & Hers Health, Inc. | 0.0893 |
| Abbott Laboratories | 1.030 |
| Enovis Corp. | -9.074 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 180.00M |
| Revenue (Quarterly) | 7.787B |
| Total Expenses (Quarterly) | 7.605B |
| Enterprise Value | 54.30B |
| Gross Profit Margin (Quarterly) | 22.32% |
| Profit Margin (Quarterly) | 2.31% |
| Earnings Yield | 3.38% |
| Operating Earnings Yield | 6.58% |
| Normalized Earnings Yield | 3.434 |